Found 7 matching trials
Natural Killer(NK) Cell Therapy in Acute Myeloid Leukemia
PHASE1This is a phase 1, first-in-human (FIH), open-label, multicohort study to e...
Location
Institute of Hematology & Blood Diseases Hospital
Phase I/II Clinical Trial of Universal Donor CD33 CAR Natural Killer Cells for AML
PHASE1This phase 1/2 study is testing a new treatment for acute myeloid leukemia ...
Location
Nationwide Children's Hospital
CAR-pNK Cell Immunotherapy for Relapsed/Refractory CD33+ AML
PHASE1The purpose of this clinical trial is to study genetically engineered NK92 ...
Location
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Anti-CD33 CAR NK Cells in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia
PHASE1CAR technology has been used in T cell therapy and gets great success in tr...
Location
Department of Hematology, Xinqiao Hospital
Study of Anti-CD33/CLL1 CAR-NK in Acute Myeloid Leukemia
EARLY_PHASE1This is an open-label, nonrandomized, investigator-initiated clinical trial...
Location
Wuxi People's Hospital
Natural Killer(NK) Cell Therapy Targeting CLL1 or CD33 in Acute Myeloid Leukemia
PHASE1This is a phase 1, first-in-human (FIH), open-label, multicohort study to e...
Location
the First Affiliated Hospital, School of Medicine, Zhejiang University
SENTI-202: Off-the-shelf Logic Gated CAR NK Cell Therapy in Adults With CD33 and/or FLT3 Blood Cancers Including AML/MDS
PHASE1This is an open-label study of the safety, biodynamics, and anti-cancer act...
Status
Active Not Recruiting
Location
UCLA Medical Center